Biologics R&D: select news

Development of New Live-Attenuated Vaccine Candidates Lacking Antibody-Dependent Enhancement (ADE) Against Dengue

https://pubmed.ncbi.nlm.nih.gov/40432141/

jeanfrancoismaison

May 291 min read

Generation of a Transgenic Plasmodium cynomolgi Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Testing P. vivax CSP-Based Malaria Vaccines in Non-Human Primates

https://pubmed.ncbi.nlm.nih.gov/40432145/

jeanfrancoismaison

May 291 min read

Plasmodium and Host Immunity: Evasion Strategies and Advances in Malaria Vaccination

https://pubmed.ncbi.nlm.nih.gov/40432384/

jeanfrancoismaison

May 291 min read

Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma

https://pubmed.ncbi.nlm.nih.gov/40424183/

jeanfrancoismaison

May 291 min read

Paving the path ForwARd: Advances and challenges in androgen receptor targeting in breast cancer

https://pubmed.ncbi.nlm.nih.gov/40424861/

jeanfrancoismaison

May 281 min read

Monoclonal Antibodies Against Myeloid Leukemia Cells: Current Knowledge and Future Directions

https://pubmed.ncbi.nlm.nih.gov/40429716/

jeanfrancoismaison

May 281 min read

Facing the Challenge to Mimic Breast Cancer Heterogeneity: Established and Emerging Experimental Preclinical Models Integrated with Omics Technologies

https://pubmed.ncbi.nlm.nih.gov/40429718/

jeanfrancoismaison

May 281 min read

Potential for a Combined Oral Inactivated Whole-Cell Vaccine Against ETEC and Shigella: Preclinical Studies Supporting Feasibility

https://pubmed.ncbi.nlm.nih.gov/40432122/

jeanfrancoismaison

May 281 min read

Malaria Vaccines: Current Achievements and Path Forward

https://pubmed.ncbi.nlm.nih.gov/40432151/

jeanfrancoismaison

May 281 min read

HDAC6 inhibition by ITF3756 modulates PD-L1 expression and monocyte phenotype: insights for a promising immune checkpoint blockade co-treatment therapy

https://pubmed.ncbi.nlm.nih.gov/40433358/

jeanfrancoismaison

May 281 min read

Toxicity assessment of the novel psychoactive substance HU-210 (Hebrew University 210; CAS: 112830-95-2): first insight into toxicophores and critical toxicity parameters (acute toxicity, health effec

https://pubmed.ncbi.nlm.nih.gov/40419203/

jeanfrancoismaison

May 271 min read

Nonclinical Safety Evaluation of 2-Deoxy-D-Glucose Following Twice-Daily Oral Administration for 28 Days in Beagle Dogs

https://pubmed.ncbi.nlm.nih.gov/40420413/

jeanfrancoismaison

May 271 min read

Maternal Embryonic Leucine Zipper Kinase (MELK) as a Promising Therapeutic Target in Triple Negative Breast Cancer

https://pubmed.ncbi.nlm.nih.gov/40417748/

jeanfrancoismaison

May 271 min read

Comparative Analysis of Animal Models in Wound Healing Research and the Utility for Humanized Mice Models

https://pubmed.ncbi.nlm.nih.gov/40418175/

jeanfrancoismaison

May 271 min read

Emerging strategies for targeting tumor-associated macrophages in glioblastoma: A focus on chemotaxis blockade

https://pubmed.ncbi.nlm.nih.gov/40419107/

jeanfrancoismaison

May 271 min read

Porcine intestinal organoids cultured in an organ-on-a-chip microphysiological system

https://pubmed.ncbi.nlm.nih.gov/40421277/

jeanfrancoismaison

May 271 min read

Nanotechnology-driven advances in intranasal vaccine delivery systems against infectious diseases

https://pubmed.ncbi.nlm.nih.gov/40416956/

jeanfrancoismaison

May 271 min read

Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC): Protocol for Multicenter Prospective Noninterventional Study

https://pubmed.ncbi.nlm.nih.gov/40418566/

jeanfrancoismaison

May 271 min read

Disassembly and reassembly of AP205 virus-like particles and the removal of bound RNA for cargo encapsulation

https://pubmed.ncbi.nlm.nih.gov/40419056/

jeanfrancoismaison

May 271 min read

Immune, metabolic, anatomical, and functional features of people after successful tuberculosis treatment: an exploratory analysis

https://pubmed.ncbi.nlm.nih.gov/40419526/

jeanfrancoismaison

May 271 min read